Skip to content

Determine how best electronic personal health records (PHRs) should be designed and utilised to help patients get the full benefit of their prescribed medication

A mixed methods realist evaluation of electronic personal health records design and use to help patients get the full benefit of their prescribed medication

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN13014819
Enrollment
30
Registered
2018-06-13
Start date
2018-11-01
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any Long Term Condition Not Applicable Any Long Term Condition

Interventions

A purposive sample of approx. 30-40 volunteers will be recruited. Posters are displayed in GP surgeries, pharmacies, and Universities across Hampshire. A project website has been developed. Potential
2. Gender
3. Ethnicity
4. Education
5. Financial status
6. Marital status
7. Employment. Medication adherence is measured using the Medication adherence questionnaire (MAQ). Quality of life is measured using the SF-36 scale, and personality t

Sponsors

University of Portsmouth
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Participant is willing and able to provide informed consent for participation in the study 2. Male or female, aged 18 years or above 3. Participant has at least one long term condition and is treated outside hospital 4. Participant can self-administer and manage his/her medication 5. Participant is frequently (at least once a week) using a PHR to manage in full or partially his/her medication 6. Participant is able to communicate freely

Exclusion criteria

Exclusion criteria: 1. Participants that are pregnant or terminally ill or considered vulnerable adults and cancer patients 2. Adults with medically serious problems that are not classified as long term conditions 3. Patients require assistance with taking their medication 4. Patients unable to communicate or unable to self-manage their medication. 5. Inpatients or patients living in care homes

Design outcomes

Primary

MeasureTime frame
Medication adherence is measured using the Medication adherence questionnaire (MAQ) at the interview

Secondary

MeasureTime frame
1. Health related quality of life score is measured using the SF-36 scale at the interview 2. Personality traits are assessed using the BFI questionnaire at the interview

Countries

United Kingdom

Contacts

Public ContactElisavet Andrikopoulou

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026